Ovid Therapeutics Inc. - OVID

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
May 15, 2026 SCHEDULE 13G/A Point72 Asset Management, L.P. 1.3% 1,903,943 View
May 15, 2026 SCHEDULE 13G/A Point72 Capital Advisors, Inc. 1.3% 1,903,943 View
May 15, 2026 SCHEDULE 13G/A Steven A. Cohen 1.3% 1,903,943 View
May 15, 2026 SCHEDULE 13G Eventide Asset Management, LLC 7.3% 12,773,577 View
May 15, 2026 SCHEDULE 13G Finny Kuruvilla, M.D., Ph. D. 7.3% 12,773,577 View
May 15, 2026 SCHEDULE 13G Robin C. John 7.3% 12,773,577 View
May 15, 2026 SCHEDULE 13G Sirenia Capital Management LP 9.9% 18,031,333 View
May 15, 2026 SCHEDULE 13G Alex Silverstein 9.9% 18,031,333 View
May 15, 2026 SCHEDULE 13G Balyasny Asset Management L.P. 5.33% 7,029,223 View
May 15, 2026 SCHEDULE 13G BAM GP LLC 5.33% 7,029,223 View
May 15, 2026 SCHEDULE 13G Balyasny Asset Management Holdings LP 5.33% 7,029,223 View
May 15, 2026 SCHEDULE 13G Dames GP LLC 5.33% 7,029,223 View
May 15, 2026 SCHEDULE 13G Dmitry Balyasny 5.33% 7,029,223 View
May 14, 2026 SCHEDULE 13G/A Jeremy M. Levin 4.5% 8,551,502 View
May 14, 2026 SCHEDULE 13G/A Affinity Asset Advisors, LLC 9.1% 15,635,484 View
May 14, 2026 SCHEDULE 13G/A Michael Cho 9.1% 15,635,484 View
Feb 17, 2026 SCHEDULE 13G ADAR1 Capital Management, LLC 6.9% 9,284,166 View
Feb 17, 2026 SCHEDULE 13G ADAR1 Capital Management GP, LLC 6.9% 9,284,166 View
Feb 17, 2026 SCHEDULE 13G Daniel Schneeberger 6.9% 9,284,166 View
Jan 29, 2026 SCHEDULE 13G/A Affinity Asset Advisors, LLC 9.0% 12,149,166 View
Jan 29, 2026 SCHEDULE 13G/A Michael Cho 9.0% 12,149,166 View
Jan 05, 2026 SCHEDULE 13G Point72 Asset Management, L.P. 5.1% 6,727,209 View
Jan 05, 2026 SCHEDULE 13G Point72 Capital Advisors, Inc. 5.1% 6,727,209 View
Jan 05, 2026 SCHEDULE 13G Steven A. Cohen 5.1% 6,727,209 View
Dec 18, 2025 SCHEDULE 13G RA Capital Management, L.P. 9.9% 13,259,735 View
Dec 18, 2025 SCHEDULE 13G Peter Kolchinsky 9.9% 13,259,735 View
Dec 18, 2025 SCHEDULE 13G Rajeev Shah 9.9% 13,259,735 View
Dec 18, 2025 SCHEDULE 13G RA Capital Healthcare Fund, L.P. 9.9% 13,259,735 View
Dec 18, 2025 SCHEDULE 13G Affinity Asset Advisors, LLC 9.0% 12,149,166 View
Dec 18, 2025 SCHEDULE 13G Affinity Healthcare Fund, LP 9.0% 12,149,166 View
Dec 09, 2025 SCHEDULE 13G/A Takeda Pharmaceutical Company Limited 12.3% 8,781,996 View
Dec 09, 2025 SCHEDULE 13G/A Takeda Pharmaceutical U.S.A., Inc. 9.8% 7,000,000 View
Dec 08, 2025 SCHEDULE 13G JANUS HENDERSON GROUP PLC 9.99% 7,114,114 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.